Listen to today’s podcast: https://www.youtube.com/channel/UC-nqwUyvLDEvs7bV985k-gQ
Stock Market Daily Podcast — October 28, 2025
Today’s podcast episode was created from the following stories:
Stocks Hit Record, Dollar Eases on US-China Trade Optimism
Global equities notched a fresh intraday record while the dollar softened as hopes grew for a potential U.S.–China trade deal. Traders are also bracing for a packed slate of central bank meetings and corporate earnings. The setup points to a tentative risk-on tone heading into policy updates.
Playing With Fire — Equitas Capital’s Guide to Sky-High Stocks
The piece argues U.S. stocks are priced for perfection, citing a Buffett Indicator above 217% and a near-40 Shiller P/E, with banks projecting subdued long-term returns. Despite stretched valuations, the author highlights strategies like dividend income, select energy/value pockets, and tactical allocation. The takeaway: balance participation with protection amid extreme valuations.
The Hidden Signals in Halliburton’s Q3 You Probably Missed
Halliburton beat expectations despite slight year-over-year declines, buoyed by $100M in quarterly cost savings and a $10B+ backlog. Management is leaning into higher-margin international work, technology like its Zeus electric frac fleet, and disciplined capacity management. These signals point to efficiency gains and better through-cycle resilience.
Shopify Stock to Crash to $120?
After a 21% surge to about $173, the analysis flags valuation risk and posits downside toward $120 despite Shopify’s strong growth and balance sheet. The note frames SHOP as a high-quality business priced richly relative to fundamentals. Investors may consider trimming or waiting for a better entry.
Is It Time to Buy BMY Stock?
Bristol Myers Squibb screens as a value with healthy margins and a discounted price-to-sales multiple near 1.9. While legacy drugs face generic pressure and guidance is mixed, pipeline catalysts and momentum in cardiovascular/hematology offer offsets. The case hinges on predictable cash flows at a reasonable price.
Has Regeneron Stock Quietly Become a Value Buy?
Regeneron trades well below its one-year peak and under recent average valuation multiples despite solid cash generation and margins. Core franchises like Dupixent and Eylea remain strong, with a diversified late-stage pipeline. The setup suggests a potential value opportunity with defensible fundamentals.
SJM Stock to $150?
JM Smucker boasts an estimated 6.2% free cash flow yield, steady growth and margins, and trades below recent highs and historical sales multiples. As a staples name, it offers cash returns and resilience, though it isn’t immune to broad selloffs. The thesis centers on income and valuation support.
What Is Happening With KLA Stock?
KLA has surged on robust revenue/EPS beats and structural tailwinds from AI/HPC spending. With dominant share in process control and growing advanced packaging exposure, management sees a larger equipment cycle ahead. The opportunity looks compelling but historically volatile.
Time to Book Profits in CRWD Stock?
CrowdStrike is up sharply YTD and near highs after upbeat events and upgrades, but the analysis argues valuation—price-to-sales around 30x and price-to-free cash flow about 126x—is stretched. Growth remains exceptional with strong cash flow and a robust balance sheet, yet the note favors patience on entry price. Expect volatility around lofty expectations.
Get Ready—Countdown to the ‘Mother-of-All’ Fed Pivots Begins as the Bitcoin Price Suddenly Soars
The article links bitcoin’s weekend surge above $116,000 to expectations the Fed could end quantitative tightening and ease policy, boosting liquidity. Commentators point to falling bank reserves, ETF demand, and a broader shift back to risk-on as tailwinds. Bulls see a potential “mother-of-all” liquidity pivots driving further upside.
Forget Market Technicals, Trump Trades Are Almost a Sure Thing
The story chronicles instances where public comments or social posts from administration officials coincided with sharp market moves—from GameStop and Argentina to Tesla, tariffs, and oil. While not insider trading, the pattern raises ethical questions about signaling and market influence. The broader lesson: policy communication, formal or informal, can be a powerful catalyst.
